Epidermal Langerhans Cells Act as Neuroimmune Regulators of Pain and Itch

Recent research has uncovered a crucial role for epidermal Langerhans cells (LCs) in modulating pain and itch sensations. Immune cells in the skin, known as LCs, play a significant part in coordinating immune defense and somatosensory perception. However, the exact mechanisms by which these cells influence sensory signaling have been largely unknown until now.

Through detailed anatomical and transcriptomic studies, the researchers discovered that LCs have a unique preference for associating with non-peptidergic sensory neurons. When activated, LCs boost both neuronal and behavioral reactions to various stimuli, such as heat, touch, and itchy sensations. Notably, this amplification occurs without directly activating the sensory neurons themselves.

To identify potential mediators involved in this process, the scientists zeroed in on a molecule called semaphorin 7A, which is expressed by LCs. They found that semaphorin 7A makes sensory neurons more responsive to substances like chloroquine and histamine. By neutralizing semaphorin 7A, they were able to effectively stop the increase in chloroquine-induced scratching caused by LC activation.

Moreover, they discovered that PlexinC1, a receptor, is expressed by most MrgprA3 pruriceptors—cells responsible for detecting itchy stimuli. Blocking PlexinC1 reduced the effect of semaphorin 7A on neuronal responses, further confirming its role in this process.

In summary, this groundbreaking study sheds light on how epidermal LCs act as local immune-derived amplifiers that regulate the responsiveness of cutaneous sensory circuits. The researchers have identified semaphorin 7A as a key mediator of LC-induced itch potentiation, offering valuable insights into the complex interplay between the immune system and sensory perception in the skin.